Fracture healing, delayed union and nonunion · Review · 2025
Can shockwave ease pain after a broken bone?
This review covered 39 trials of physical treatments for fractures, and one tested shockwave. In that study, pain eased more with shockwave than in the comparison group, by about 0.5 points. The review gave no clear healing results for shockwave.
Possible early help for pain after a fracture- trials of physical treatments for fractures
- 39
- of them tested shockwave
- 1
- people in the whole review
- 2,379
Good to know: Only one study in this review used shockwave, and its treatment details were not given.
Li L, Yang L, Yang Y, et al. Frontiers in Medicine, 2025 · Read the paper ↗
How this study worked
What happened
- shockwave studies
- 1
- Compared with
- No added treatment (the trial's control group)
Pain relief after a fracture
Extra pain relief with shockwave, in pain-scale points
Show the numbers
| Difference (pain score points) | likely range | |
|---|---|---|
| Pain relief, shockwave vs comparison | +0.52 | 0.16 to 0.88 |
What the trials used
- ESWT for fracture care
- The review included one ESWT study among 39 RCTs; no ESWT-specific device, energy, shock count or session protocol is stated in the accessible Results. The review reports ESWT subgroup findings for pain and complete fracture healing, but individual-trial protocol details are not available in the extracted main text.
Who took part
Adults and children with fresh or slow-healing fractures in 39 trials; one trial used shockwave.
Side effects
The review does not report side effects.
All the numbers and the full appraisal
The results, in numbers.
Adults and children with fractures or delayed fracture healing; 39 RCTs (2,379 participants) covered multiple fracture sites and modalities. Only one included study evaluated ESWT.
Difference between pre-treatment and after-final-session VAS; positive MD indicates improvement as defined by article1 reported outcome
Pain reduction after fracture
Difference between pre-treatment and after-final-session VAS; positive MD indicates improvement as defined by article MD VAS points (95% CI)
ESWT subgroup versus control group (Table 1 lists the trial’s comparator as “none”); positive difference represents pain reduction
1 study
The review reported a statistically significant pain reduction estimate for the single ESWT study (MD 0.52, 95% CI 0.16 to 0.88; p=0.004).
Analysis details and source
Pain synthesis showed high overall heterogeneity (I² 90.8%). I² could not be calculated for ESWT because only one study contributed. Follow-up across the broader outcome ranged 5 days to 6 months. Table 1 lists a 12-month follow-up for the single ESWT study (Wang et al.), longer than the 5-day to 6-month range the text gives for the pain outcome; the review does not say when that study’s pain score was taken. In the network meta-analysis, the review gives ESWT vs LLLT MD −1.74 (95% CI −3.94 to 0.45) among the comparisons suggesting LLLT may relieve post-fracture pain more, and Table 2 gives ESWT a SUCRA of 41.0% for pain.
Number of cases achieving complete fracture healing1 reported outcome
Complete fracture healing
Number of cases achieving complete fracture healing ESWT-versus-control RR not reported in narrative
The review reports overall physical modalities RR 1.37 (95% CI 1.17–1.60) versus control, but does not give the ESWT-versus-control subgroup estimate in the narrative (it appears only in Figure 3C, which was not available). Do not attribute the overall estimate to ESWT.
Analysis details and source
The NMA found most pairwise modality comparisons included the null; for ESWT the text reports CCEFS vs ESWT RR 12.61 (95% CI 0.70 to 228.37), and main-text Table 2 gives ESWT a SUCRA of 30.20% for complete healing. The full ranking table of pairwise comparisons (Supplementary Table 2) was unavailable.
How treatment was delivered
The review included one ESWT study among 39 RCTs; no ESWT-specific device, energy, shock count or session protocol is stated in the accessible Results. The review reports ESWT subgroup findings for pain and complete fracture healing, but individual-trial protocol details are not available in the extracted main text.
The review did not provide ESWT-specific adverse-event counts. The Discussion mentions possible secondary injury, hematoma and increased pain as potential ESWT risks, not observed trial rates.
Only one study evaluated ESWT; fracture sites, populations, treatment duration and device parameters varied across the overall review. Heterogeneity was high for pain (I² 90.8%) and confidence intervals and relative comparisons were often imprecise. Study-level protocol details are not given in the main text, and the supplementary ranking table of pairwise comparisons (Supplementary Table 2) was not retrieved. SUCRA rankings do not incorporate evidence quality.
Findings checked against the full source by a separate automated reviewer.
Limitations noted by the reviewers
- Only one study evaluated ESWT; fracture sites, populations, treatment duration and device parameters varied across the overall review. Heterogeneity was high for pain (I² 90.8%) and confidence intervals and relative comparisons were often imprecise. Study-level protocol details are not given in the main text, and the supplementary ranking table of pairwise comparisons (Supplementary Table 2) was not retrieved. SUCRA rankings do not incorporate evidence quality.
Source-linked critical reading
Systematic review with network meta-analysis
Technical source record
Read complete XML, both raw tables, six figure captions, study-selection/characteristics, ESWT pain and healing analyses, network narrative, harms discussion, limitations and end matter. Supplementary rankings were unavailable.
One study reported less pain after ESWT, but this review cannot establish comparative fracture-healing benefit or an effective treatment protocol.
In patients with fractures or delayed healing, how do physical agent modalities compare for pain relief and fracture healing?
Systematic review and network meta-analysis of randomized trials registered in PROSPERO (CRD420251030229), with searches through April 2025. Thirty-nine RCTs and 2,379 participants were included.
Included fracture patients ranged from age 5 to 72 years according to the text (Table 1 lists group mean ages up to 80.26 years), with varied fracture sites and healing status. Only one included study evaluated ESWT.
The review categorized ESWT among physical agent modalities but does not provide sufficient ESWT-specific device or treatment parameters in accessible main-text results.
Control groups received placebo stimulation or standard treatment; the single ESWT study’s exact comparator details are not reproduced with its pain result in the narrative.
The review assessed pain change, time to complete healing and number of complete healing cases. For pain, the single-study ESWT subgroup estimate was MD 0.52 (95% CI 0.16 to 0.88; p=0.004); positive difference was defined by the article as improvement.
Pain analyses had substantial overall heterogeneity (I² 90.8%). A single ESWT study contributed, so subgroup heterogeneity could not be estimated. The review’s overall complete-healing RR must not be attributed to ESWT.
No ESWT-specific adverse-event counts were reported. Potential hematoma, increased pain and secondary injury were discussed as possible risks, not trial event rates.
The review included one ESWT study amid diverse fracture populations and modalities. Study protocol details and the supplementary pairwise ranking table (Supplementary Table 2) were unavailable; confidence and generalizability are limited.
This is preliminary evidence from a single study and does not establish a reliable ESWT effect for any particular fracture type or treatment protocol.
Future trials should report fracture type, healing stage, device settings, treatment schedule, comparator, validated pain measures, healing definitions, harms and adequately powered comparative outcomes.
Read the original article.
Evaluation of the efficacy of physical agent modalities in patients with fractures: a systematic review and network meta-analysis.
Li L, Yang L, Yang Y, Zhu J, Shi R, Deng Q, Wang J, Sun F. · Frontiers in medicine · 2025
Open the publication record or available full-text files.
Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →